The Quantum Biology DAO accelerates the quantum biology field through community building, open governance, scientific experimentation, research grants, and IP development.
The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model.
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief.
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT.
BiomeAI is a cutting-edge health assistant powered by over 1,000 rigorously curated scientific studies on microbiome science and real-world experiments, designed to help people make smarter, personalized health choices with trustworthy data as its foundation.
Quantum Biology DAO
Neuron-Gale
Relieva
eDMT Commons
BiomeAI
0.41%
